These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26267532)

  • 1. Intercepting Cancer Communiques: Exosomes as Heralds of Malignancy.
    Hingorani SR
    Cancer Cell; 2015 Aug; 28(2):151-3. PubMed ID: 26267532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.
    Melo SA; Luecke LB; Kahlert C; Fernandez AF; Gammon ST; Kaye J; LeBleu VS; Mittendorf EA; Weitz J; Rahbari N; Reissfelder C; Pilarsky C; Fraga MF; Piwnica-Worms D; Kalluri R
    Nature; 2015 Jul; 523(7559):177-82. PubMed ID: 26106858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic cancer and associated exosomes.
    Zhao C; Gao F; Weng S; Liu Q
    Cancer Biomark; 2017 Dec; 20(4):357-367. PubMed ID: 29036786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Exosomal GPC1, CD82, and Serum CA19-9 as Multiplex Targets: A Specific, Sensitive, and Reproducible Detection Panel for the Diagnosis of Pancreatic Cancer.
    Xiao D; Dong Z; Zhen L; Xia G; Huang X; Wang T; Guo H; Yang B; Xu C; Wu W; Zhao X; Xu H
    Mol Cancer Res; 2020 Feb; 18(2):300-310. PubMed ID: 31662449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Exosomes in Pancreatic Cancer: Will They Succeed on the Long, Littered Road to Early Detection Marker?
    Babic A; Wolpin BM
    Clin Chem; 2016 Feb; 62(2):307-9. PubMed ID: 26721295
    [No Abstract]   [Full Text] [Related]  

  • 6. ATF1 and RAS in exosomes are potential clinical diagnostic markers for cervical cancer.
    Shi Y; Wang W; Yang B; Tian H
    Cell Biochem Funct; 2017 Oct; 35(7):477-483. PubMed ID: 29023897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity.
    Madhavan B; Yue S; Galli U; Rana S; Gross W; Müller M; Giese NA; Kalthoff H; Becker T; Büchler MW; Zöller M
    Int J Cancer; 2015 Jun; 136(11):2616-27. PubMed ID: 25388097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes: potential for early detection in pancreatic cancer.
    Lu L; Risch HA
    Future Oncol; 2016; 12(8):1081-90. PubMed ID: 26860951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers: The challenge to find biomarkers for the early detection of pancreatic cancer.
    Weber C
    Nat Rev Gastroenterol Hepatol; 2015 Aug; 12(8):427. PubMed ID: 26170217
    [No Abstract]   [Full Text] [Related]  

  • 10. K-ras mutations in circulating DNA from pancreatic and lung cancers: bridging methodology for a common validation of the molecular diagnosis value.
    Magistrelli P; Neri M; Granone P; Cesario A; Paleari L; Russo P
    Pancreas; 2008 Jul; 37(1):101-2. PubMed ID: 18580451
    [No Abstract]   [Full Text] [Related]  

  • 11. The Role of Exosomes in Pancreatic Cancer.
    Lan B; Zeng S; Grützmann R; Pilarsky C
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31487880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour-derived exosomes as a signature of pancreatic cancer - liquid biopsies as indicators of tumour progression.
    Nuzhat Z; Kinhal V; Sharma S; Rice GE; Joshi V; Salomon C
    Oncotarget; 2017 Mar; 8(10):17279-17291. PubMed ID: 27999198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress and potential of exosome analysis for early pancreatic cancer detection.
    Erb U; Zöller M
    Expert Rev Mol Diagn; 2016 Jul; 16(7):757-67. PubMed ID: 27206554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of pancreatic cancer-derived exosomes in cancer progress and their potential application as biomarkers.
    Jin H; Wu Y; Tan X
    Clin Transl Oncol; 2017 Aug; 19(8):921-930. PubMed ID: 28168600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis: Fishing for exosomes.
    Alderton GK
    Nat Rev Cancer; 2015 Aug; 15(8):453. PubMed ID: 26205334
    [No Abstract]   [Full Text] [Related]  

  • 16. Early detection tools for pancreatic cancer.
    Schmidt C
    J Natl Cancer Inst; 2012 Aug; 104(15):1117-8. PubMed ID: 22851273
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of exosomes in the pathogenesis of pancreatic ductal adenocarcinoma.
    Robinson SM; Fan L; White SA; Charnley RM; Mann J
    Int J Biochem Cell Biol; 2016 Jun; 75():131-9. PubMed ID: 27017975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glypican-1 as a highly sensitive and specific pancreatic cancer biomarker.
    Diamandis EP; Plebani M
    Clin Chem Lab Med; 2016 Jan; 54(1):e1-2. PubMed ID: 26389634
    [No Abstract]   [Full Text] [Related]  

  • 19. Combining Machine Learning and Nanofluidic Technology To Diagnose Pancreatic Cancer Using Exosomes.
    Ko J; Bhagwat N; Yee SS; Ortiz N; Sahmoud A; Black T; Aiello NM; McKenzie L; O'Hara M; Redlinger C; Romeo J; Carpenter EL; Stanger BZ; Issadore D
    ACS Nano; 2017 Nov; 11(11):11182-11193. PubMed ID: 29019651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer: Diagnosis by extracellular vesicles.
    Théry C
    Nature; 2015 Jul; 523(7559):161-2. PubMed ID: 26106856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.